STRIDES PHARMA SCISTRIDES PHARMA SCISTRIDES PHARMA SCI

STRIDES PHARMA SCI

No trades
See on Supercharts
Market capitalization
‪76.96 B‬INR
−16.85INR
‪−2.21 B‬INR
‪36.68 B‬INR
‪62.82 M‬
Beta (1Y)
0.92

About STRIDES PHARMA SCI

CEO
Arun N. Kumar
Headquarters
Bangalore
Employees (FY)
‪4.62 K‬
Founded
1990
ISIN
INE939A01011
FIGI
BBG000DQV3B4
Strides Pharma Science Ltd. engages in the development, manufacture and distribution of Internet Protocol-led generics and bio-pharmaceutical products. It operates through the Pharmaceutical and Bio-pharmaceutical business segments. The company was founded by Arun N. Kumar on June 28, 1990 and is headquartered in Bangalore, India.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of STAR is 844.85 INR — it has increased by 0.64% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange STRIDES PHARMA SCI stocks are traded under the ticker STAR.
STRIDES PHARMA SCI is going to release the next earnings report on May 23, 2024. Keep track of upcoming events with our Earnings Calendar.
STAR stock is 2.39% volatile and has beta coefficient of 0.92. Check out the list of the most volatile stocks — is STRIDES PHARMA SCI there?
One year price forecast for STRIDES PHARMA SCI has a max estimate of 965.00 INR and a min estimate of 710.00 INR.
STRIDES PHARMA SCI revenue for the last quarter amounts to ‪9.99 B‬ INR despite the estimated figure of ‪9.70 B‬ INR. In the next quarter revenue is expected to reach ‪10.16 B‬ INR.
Yes, you can track STRIDES PHARMA SCI financials in yearly and quarterly reports right on TradingView.
STAR stock has risen by 0.58% compared to the previous week, the month change is a 5.67% rise, over the last year STRIDES PHARMA SCI has showed a 166.89% increase.
STAR net income for the last quarter is ‪−44.81 M‬ INR, while the quarter before that showed ‪−1.31 B‬ INR of net income which accounts for 96.59% change. Track more STRIDES PHARMA SCI financial stats to get the full picture.
Today STRIDES PHARMA SCI has the market capitalization of ‪76.96 B‬, it has increased by 2.30% over the last week.
Yes, STAR dividends are paid annually. The last dividend per share was 1.50 INR. As of today, Dividend Yield (TTM)% is 0.18%. Tracking STRIDES PHARMA SCI dividends might help you take more informed decisions.
Like other stocks, STAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade STRIDES PHARMA SCI stock right from TradingView charts — choose your broker and connect to your account.
STAR reached its all-time high on Nov 23, 2015 with the price of 1323.15 INR, and its all-time low was 20.35 INR and was reached on Jul 19, 2001.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪4.62 K‬ employees. See our rating of the largest employees — is STRIDES PHARMA SCI on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So STRIDES PHARMA SCI technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating STRIDES PHARMA SCI stock shows the buy signal. See more of STRIDES PHARMA SCI technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on STRIDES PHARMA SCI future price: according to them, STAR price has a max estimate of 965.00 INR and a min estimate of 710.00 INR. Read a more detailed STRIDES PHARMA SCI forecast: see what analysts think of STRIDES PHARMA SCI and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. STRIDES PHARMA SCI EBITDA is ‪6.69 B‬ INR, and current EBITDA margin is 9.98%. See more stats in STRIDES PHARMA SCI financial statements.